Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViaLactia Biosciences was a New Zealand-based biotechnology company and a subsidiary of Fonterra, the world's largest dairy exporter. The company specialized in dairy genomics, focusing on identifying and commercializing genes that influence milk composition, animal health, and forage quality. Its most prominent research included the discovery of a natural genetic variant for low-fat milk and the development of genetically modified ryegrass designed to increase the nutritional value of dairy products. ViaLactia's work integrated advanced molecular markers into traditional breeding programs to accelerate agricultural innovation. The company's operations were eventually integrated back into Fonterra's core research and development divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViaLactia Biosciences.